http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113509486-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-0012 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08G83-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P39-02 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08B37-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-795 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08G83-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-02 |
filingDate | 2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113509486-B |
titleOfInvention | Application of CCA-CD co-assembly in the preparation of macromolecular toxin detoxification drugs |
abstract | The invention relates to the application of a CCA-CD co-assembly in the preparation of macromolecular toxin detoxification drugs. The co-assembly CCA‑CD can effectively complex melittin, spider venom and snake venom to alleviate their cytotoxicity, and has the potential to treat the poisoning of these toxic macromolecules. Each component of CCA-CD has a clear chemical structure and good batch reproducibility. CCA-CD has high chemical stability and thermal stability, and does not affect the activity of important proteins in organisms, and has good biocompatibility. |
priorityDate | 2021-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 125.